{"id":"W3030967068","doi":"10.1200/jco.2020.38.15_suppl.tps3656","title":"An open-label, first-in-human, phase I trial of the safety and efficacy of daily PCLX-001.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Spinal Cord Injury BC","funders":"","keywords":"Tolerability; Medicine; Pharmacokinetics; In vivo; Lymphoma; Cancer; Internal medicine; Oncology; Pharmacology; Cancer research; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001286708,0.002038059,0.001460326,0.0004854153,0.0005346944,0.001274942,0.001151628,0.00162669,0.006549635],"category_scores_gemma":[0.0008795982,0.0006394461,0.0007717906,0.0004099823,0.001552789,0.001583375,0.0004432432,0.003865924,0.001286632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001438753,"about_ca_system_score_gemma":0.001615665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009342644,"about_ca_topic_score_gemma":0.001503644,"domain_scores_codex":[0.9996006,0.0001253147,0.00001702473,0.0001162616,0.00004051763,0.000100345],"domain_scores_gemma":[0.9990785,0.0001205929,0.0001922856,0.000105053,0.00004790696,0.000455697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6223329,0.1552303,0.003377162,0.0007341395,0.0006037562,0.0004461352,0.0003868866,0.002782337,0.1003108,0.0006149401,0.008429832,0.1047509],"study_design_scores_gemma":[0.3382849,0.6404737,0.005474811,0.00002184807,0.0001661902,0.0005024151,0.00007837165,0.001591536,0.00849823,0.0003650353,0.004512145,0.00003072499],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988093,0.001321048,0.001227256,0.0005280843,0.0001686621,0.003629853,0.002091785,0.0002991032,0.002641225],"genre_scores_gemma":[0.9836621,0.0009123115,0.002223683,0.0009251993,0.0001724483,0.00283018,0.003671497,0.00008180501,0.005520786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006549635,"threshold_uncertainty_score":0.02191067,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1866808923102349,"score_gpt":0.5238295491597984,"score_spread":0.3371486568495635,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}